Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2025 05:01 ET | Source: Research and Markets

Anti-CD279 (PD-1) Antibody Pipeline Insight Report 2025 Featuring Analysis of 40+ Companies & Drugs Including IBI308 (Innovent Biologics) and Tislelizumab (BeiGene)

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
July 01, 2024 07:54 ET | Source: Research and Markets

Advanced Liver Cancer Therapeutics Research 2024: Comprehensive Insights About 50+ Companies and 50+ Pipeline Drugs - Product Type, Stage, Route of Administration, and Molecule Type

Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Advanced liver cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Advanced liver cancer -...
April 23, 2024 07:29 ET | Source: Research and Markets

Gastric Cancer Drug Pipeline Research 2024: Significant Advancements and Numerous Therapies with Over 200 in Development

Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The "Gastric Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The latest insights into the Gastric Cancer...
April 11, 2024 09:15 ET | Source: Research and Markets

Anti-CD279 (PD-1) Antibody Drug Pipeline Research Report 2024: Insights on 40+ Companies Featuring GlaxoSmithKline, Innovent Biologics, BeiGene, and Shanghai Junshi Biosciences

Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Anti-CD279 (PD-1) Antibody - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Anti-CD279 (PD-1)...
January 24, 2024 13:26 ET | Source: Research and Markets

Head and Neck Cancer Therapeutics Market to Reach $2.3 Billion by 2027 - New Research Report Reveals

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Head and Neck Cancer Therapeutics Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The latest research report...
May 08, 2023 06:48 ET | Source: Research and Markets

Global Checkpoint Inhibitors Competitive Landscape Report 2023: Comprehensive Insights About 180+ Companies and 250+ Drug Profiles

Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "Checkpoint inhibitors -...
September 21, 2022 07:53 ET | Source: Research and Markets

Global PD-1/PDL-1 Inhibitor Market Report 2022: Increase in PD-1/PDL-1 Inhibitor Based Combination Regimens Fueling Sector

Dublin, Sept. 21, 2022 (GLOBE NEWSWIRE) -- The "PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032" report...
March 29, 2022 05:38 ET | Source: Research and Markets

Global $140+ Billion Immune Checkpoint Inhibitors Market Opportunity Analysis and Industry Forecasts to 2030

Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...